Azithromycin in Respiratory Tract Infections
Direct Recommendation
Azithromycin should NOT be routinely prescribed for most adult respiratory tract infections—specifically avoid it for acute bronchitis, common cold, and non-streptococcal pharyngitis, as antibiotics are not indicated for these conditions. 1
When Azithromycin IS Appropriate
Adults
Community-Acquired Pneumonia (mild severity):
- Dose: 500 mg once daily on Day 1, then 250 mg once daily on Days 2-5 2
- This is the primary appropriate indication for azithromycin in adult RTIs
Acute Bacterial Sinusitis (limited indication):
- Only prescribe when symptoms persist >10 days, OR severe symptoms (fever >39°C with purulent discharge/facial pain for ≥3 consecutive days), OR "double sickening" (worsening after initial improvement) 1
- Dose: 500 mg once daily for 3 days 2
Acute Exacerbations of COPD:
- Dose: 500 mg once daily for 3 days OR 500 mg Day 1, then 250 mg Days 2-5 2
Pediatric Patients (≥6 months)
Community-Acquired Pneumonia:
- Dose: 10 mg/kg Day 1, then 5 mg/kg once daily Days 2-5 2
- Efficacy demonstrated with 95-97% cure rates 3, 4
Acute Otitis Media:
- Dose options: 30 mg/kg single dose OR 10 mg/kg once daily for 3 days OR 10 mg/kg Day 1, then 5 mg/kg Days 2-5 2
- However, azithromycin is generally NOT recommended as first-line for acute otitis media due to pneumococcal resistance concerns 5
Acute Bacterial Sinusitis:
- Dose: 10 mg/kg once daily for 3 days 2
Pharyngitis/Tonsillitis (SECOND-LINE only):
- Dose: 12 mg/kg once daily for 5 days 2
- Only use after confirming Group A Streptococcus by rapid antigen test or culture 1
- Not first-line due to resistance concerns 5
Critical Contraindications and Warnings
Absolute Contraindications:
- Avoid in patients at significant risk of bacteremia 5
- History of cholestatic jaundice or hepatic dysfunction with prior azithromycin use 2
- Known hypersensitivity to azithromycin, erythromycin, or any macrolide/ketolide antibiotic 2
Major Safety Concerns:
- Cardiac risk: Rare cases of torsades de pointes—use extreme caution in patients with prolonged QT interval, arrhythmias, uncorrected hypokalemia/hypomagnesemia, or on QT-prolonging medications 6
- Hepatic impairment: No dosage adjustment data available; use with caution 2
- Severe renal impairment (GFR <10 mL/min): AUC increases 35%; use with caution 2
Resistance Considerations:
Azithromycin is associated with pneumococcal resistance and should be avoided for pneumococcal infections when possible 5. This is particularly important given that azithromycin and erythromycin (Watch group antibiotics) are among the most frequently prescribed, contributing to resistance patterns 7.
Common Pitfalls to Avoid
DO NOT prescribe for acute bronchitis unless pneumonia is suspected 1—this is the most common inappropriate use
DO NOT prescribe for common cold 1—antibiotics have no role
DO NOT prescribe for pharyngitis without confirming streptococcal infection 1
Avoid empiric use in children with suspected pneumococcal disease 5—amoxicillin is preferred first-line
Do not use as first-line for acute otitis media in children 5—despite FDA approval, resistance concerns favor amoxicillin
Adverse Effects Profile
Most adverse effects are mild-to-moderate and gastrointestinal:
- Adults: Diarrhea/loose stools (4-7%), nausea (3-18% depending on dose), abdominal pain (2-7%) 2
- Pediatric: Similar profile with diarrhea, abdominal pain, vomiting most common (≥1%) 2
- Discontinuation rate due to adverse effects: only 0.6-0.7% 2, 8
- Serious reactions (angioedema, cholestatic jaundice, Stevens-Johnson syndrome) are rare 2